Search Results for 'Tdf-Prep'

Tdf-Prep published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
Switch to DOR-TDF-3TC vs. Continued Baseline Regimen
by dorothy
DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...
Switching to TDF-FTC  from ABC-3TC for Hyperlipidemia
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switching to TAF from TDF, each with RPV and FTC
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Switch  from  TDF to TAF
Switch from TDF to TAF
by easyho
GS-US-292-0109 Study. GS-US-311-1089 Study. . De...
Switch de TDF a TAF Estudio GS-US-292-0109
Switch de TDF a TAF Estudio GS-US-292-0109
by calandra-battersby
Estudio GS-US-311-1089 . Estudio GS-US-366-1216 ....
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)
by tawny-fly
M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
by giovanna-bartolotta
“On Demand” Oral PrEP: Lessons Learned from M...
Pre-Exposure Prophylaxis ( PrEP )  for HIV Infection Jeffrey D. Klausner, MD, MPH
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
The Evidence  –  PrEP  Effectiveness
The Evidence – PrEP Effectiveness
by lindy-dunigan
Module . 1(b). The Evidence in Detail. Session Ov...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
Gilead Sciences, Inc., Foster City, CA, USA
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
The Evidence
The Evidence
by danika-pritchard
– . PrEP. Effectiveness. Module . 1(b). The Ev...
State
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
Tenofovir
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
Cabotegravir, Long-acting Injectable
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Brad  Hare Nothing to Disclose
Brad Hare Nothing to Disclose
by beatrice
Kaiser Permanente San Francisco Medical Center. Sa...
HIV  Update Ardis Moe, M.D.
HIV Update Ardis Moe, M.D.
by nonhurmer
amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Raltegravir plus Ritonavir-Boosted Darunavir  NEAT001/ANRS 143 Trial
Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial
by matthew167
NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
NRTI-sparing SPARTAN PROGRESS
NRTI-sparing SPARTAN PROGRESS
by shepard237
RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC
by felicity
ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Retirement Plan Consulting
Retirement Plan Consulting
by oconnor
Overview of Services. Table of Contents. About RPA...
HIV 2020:  Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...